CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors 1 month ago [#item_full_content] Share this: AEON Biopharma and Priveterra Acquisition Corp. Announce Additional Capital Commitment from Existing Investors for at Least $20 MillionDateJanuary 10, 2023In relation tobiotech newsTransCode Therapeutics Announces Equity Investment from White Lion Capital to Help Fund Development of TTX-MC138 for Treatment of GlioblastomasDateApril 14, 2023In relation tobiotech newsORIC Pharmaceuticals Announces $125 Million Private Placement FinancingDateJanuary 22, 2024In relation tobiotech news
